| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addendum
|
|
|
2001
|
4 |
1 |
p. 44-
1 p.
|
artikel
|
| 2 |
A Multinational Pharmacoeconomic Evaluation of Acute Major Depressive Disorder (MDD): a Comparison of Cost-Effectiveness Between Venlafaxine, SSRIs and TCAs
|
Doyle, John J.
|
|
2001
|
4 |
1 |
p. 16-31
16 p.
|
artikel
|
| 3 |
Modeling Choice Behavior for New Pharmaceutical Products
|
Bingham, Matthew F.
|
|
2001
|
4 |
1 |
p. 32-44
13 p.
|
artikel
|
| 4 |
Pharmaceutical Regulation: The Early Experience of the NHS National Institute for Clinical Excellence (NICE) Appraisal Process—Where Are We Headed? Presented at the ISPOR 5th Annual International Meeting, Crystal City, VA, 24 May 2000
|
Taylor, Rod
|
|
2001
|
4 |
1 |
p. 8-11
4 p.
|
artikel
|
| 5 |
Regulation of Pharmacoeconomics and Outcomes Research Presented at the ISPOR 5th Annual International Meeting, Crystal City, VA, 24 May 2000
|
Radensky, Paul
|
|
2001
|
4 |
1 |
p. 12-15
4 p.
|
artikel
|
| 6 |
Renewal of Our Value in Health Mission and Policy As We Enter Our Fourth Year
|
|
|
2001
|
4 |
1 |
p. 1-4
4 p.
|
artikel
|
| 7 |
US Regulation of Pharmaceutical Outcomes Research Presented at the ISPOR 5th Annual International Meeting, Crystal City, VA, 24 May 2000
|
Burke, Laurie B.
|
|
2001
|
4 |
1 |
p. 5-7
3 p.
|
artikel
|
Tijdschrift beschrijving